SEC Form 4Coverage since Jun 11, 2026
$ORKA insider trading
Over the last 12 months, Oruka Therapeutics insiders reported no purchases and 11 sales totaling $306.0M across SEC Form 4 filings. 64% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $306.0M 11 events
- Events · 12m
- 11 Form 4 filings, grouped
- Insiders · 12m
- 7 distinct reporters
- 10b5-1 share
- 64% pre-arranged plans
Side
Price · $ORKA · 12Mvia TradingView
Top insiders · 12m
Agarwal ArjunSenior Vice President, Finance3× · $1.7M
Sandler Laura LeeChief Operating Officer2× · $514K
Goncalves JoanaChief Medical Officer2× · $1.2M
Quinlan Paul TGeneral Counsel1× · $51K
Klein Lawrence OttoChief Executive Officer1× · $120K
All insider trades
11 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Goncalves JoanaChief Medical Officer · O | ▼ Sale | 7,000 | $86.28 | $604K | -17.6% | plan · 4 tranches |
| Jul 13, 2026 | Agarwal ArjunSenior Vice President, Finance · O | ▼ Sale | 9,999 | $84.63 | $846K | -39.5% | plan · 4 tranches |
| Jul 1, 2026 | Fairmount Funds Management LLCD·10% | ▼ Sale | 3,553,410 | $84.43 | $300.0M | -75.8% | indirect |
| Jul 1, 2026 | Sandler Laura LeeChief Operating Officer · O | ▼ Sale | 5,000 | $94.42 | $472K | -2.1% | plan · 3 tranches |
| Jun 22, 2026 | Agarwal ArjunSenior Vice President, Finance · O | ▼ Sale | 1,587 | $80.95 | $128K | -9.4% | plan · 2 tranches |
| Jun 15, 2026 | Agarwal ArjunSenior Vice President, Finance · O | ▼ Sale | 9,854 | $69.72 | $687K | -36.8% | plan · 4 tranches |
| Jun 15, 2026 | Goncalves JoanaChief Medical Officer · O | ▼ Sale | 7,947 | $69.28 | $551K | -19.5% | plan · 4 tranches |
| Jun 15, 2026 | Klein Lawrence OttoChief Executive Officer · O·D | ▼ Sale | 1,729 | $69.69 | $120K | -0.2% | — |
| Jun 15, 2026 | Sandler Laura LeeChief Operating Officer · O | ▼ Sale | 600 | $69.69 | $42K | -0.3% | — |
| Jun 15, 2026 | Quinlan Paul TGeneral Counsel · O | ▼ Sale | 733 | $69.69 | $51K | -2.3% | — |
| Jun 12, 2026 | Dambkowski CarlD | ▼ Sale | 35,000 | $70.13 | $2.5M | -47.5% | plan · 2 tranches |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ORKA feed.